Pfizer Says Its Booster Shot Bolsters Immune Response in Those Aged 5 to 11
THURSDAY, April 14, 2022 (HealthDay News) — Pfizer Inc. said Thursday that its booster shot raised levels of neutralizing antibodies against both the original coronavirus strain and the Omicron variant in children aged 5 to 11. They said in a statement that they would ask the U.S. Food and DrugContinue Reading










